BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C, Fontanini E, Cmet S, Minisini R, Bitetto D, Toniutto P, Pirisi M. Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol. 2010;71:999-1004. [PMID: 20655350 DOI: 10.1016/j.humimm.2010.06.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Gao S, Du B, Wang J. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis. Tumor Biol 2014;35:3551-61. [DOI: 10.1007/s13277-013-1469-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rau M, Baur K, Geier A. Host genetic variants in the pathogenesis of hepatitis C. Viruses 2012;4:3281-302. [PMID: 23342360 DOI: 10.3390/v4123281] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
3 Cachem FCOF, Dias AS, Monteiro C, Castro JR, Fernandes G, Delphim L, Almeida AJ, Tavares F, Maciel AMA, Amendola-Pires MM, Brandão-Mello CE, Bento CAM. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C. Immunology 2017;151:167-76. [PMID: 28140446 DOI: 10.1111/imm.12720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
4 Sawkulycz X, Bradburn S, Robinson A, Payton A, Pendleton N, Murgatroyd C. Regulation of interleukin 6 by a polymorphic CpG within the frontal cortex in Alzheimer's disease. Neurobiol Aging 2020;92:75-81. [PMID: 32408055 DOI: 10.1016/j.neurobiolaging.2020.04.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 da Silva CB, Vieira DA, de Melo LF, Chagas ALS, Gomes AD, Faria Jr CLL, Teixeira R, de Magalhães Queiroz DM, Rocha GA, Soares MMS, Bezerra JMT, Silva LD. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. World J Hepatol 2020; 12(4): 137-148 [PMID: 32685106 DOI: 10.4254/wjh.v12.i4.137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Panayides A, Ioakeimidou A, Karamouzos V, Antonakos N, Koutelidakis I, Giannikopoulos G, Makaritsis K, Voloudakis N, Toutouzas K, Rovina N, Bristianou M, Damoraki G, Routsi C, Giamarellos-Bourboulis EJ; Hellenic Sepsis Study Group. -572 G/C single nucleotide polymorphism of interleukin-6 and sepsis predisposition in chronic renal disease. Eur J Clin Microbiol Infect Dis 2015;34:2439-46. [PMID: 26463449 DOI: 10.1007/s10096-015-2500-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
7 Giannitrapani L, Soresi M, Balasus D, Licata A, Montalto G. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol 2013; 19(16): 2449-2455 [PMID: 23674845 DOI: 10.3748/wjg.v19.i16.2449] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
8 Zhang G, Wang W, Li S, Yang H, Zhang M, Zhang P, Wen Y, Wu A, Yang L, Zhou B, Chen X. IL6 gene allele-specific C/EBPα-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun 2015;16:528-35. [PMID: 26447433 DOI: 10.1038/gene.2015.40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
9 Mandal S, Abebe F, Chaudhary J. -174G/C polymorphism in the interleukin-6 promoter is differently associated with prostate cancer incidence depending on race. Genet Mol Res 2014;13:139-51. [PMID: 24446297 DOI: 10.4238/2014.January.10.5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
10 Lepiller Q, Tripathy MK, Di Martino V, Kantelip B, Herbein G. Increased HCMV seroprevalence in patients with hepatocellular carcinoma. Virol J. 2011;8:485. [PMID: 22032643 DOI: 10.1186/1743-422x-8-485] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
11 French AL, Evans CT, Agniel DM, Cohen MH, Peters M, Landay AL, Desai SN. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J Infect Dis. 2013;208:679-689. [PMID: 23687224 DOI: 10.1093/infdis/jit225] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
12 Sun X, Tian Q, Wang L, Xue M, Zhong G. IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract. Microbes Infect 2017;19:536-45. [PMID: 28864426 DOI: 10.1016/j.micinf.2017.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
13 Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7:536-550. [PMID: 21552420 DOI: 10.7150/ijbs.7.536] [Cited by in Crossref: 164] [Cited by in F6Publishing: 169] [Article Influence: 14.9] [Reference Citation Analysis]
14 Cengiz M, Yasar DG, Ergun MA, Akyol G, Ozenirler S. The role of interleukin-6 and interleukin-8 gene polymorphisms in non-alcoholic steatohepatitis. Hepat Mon 2014;14:e24635. [PMID: 25737730 DOI: 10.5812/hepatmon.24635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Adnan F, Khan NU, Iqbal A, Ali I, Petruzziello A, Sabatino R, Guzzo A, Loquercio G, Botti G, Khan S, Naeem M, Khan MI. Interleukin-6 polymorphisms in HCC patients chronically infected with HCV. Infect Agent Cancer 2020;15:21. [PMID: 32266003 DOI: 10.1186/s13027-020-00285-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Ali YBM, Moussa SG, Shahen SM, Dewir MA, El-Sayed IH. Association between interleukin-6 gene polymorphism and iron regulation in hemodialysis patients infected with HCV. J Bras Nefrol 2020;42:437-47. [PMID: 32720970 DOI: 10.1590/2175-8239-JBN-2019-0188] [Reference Citation Analysis]
17 Aron-wisnewsky J, Minville C, Tordjman J, Lévy P, Bouillot J, Basdevant A, Bedossa P, Clément K, Pépin J. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. Journal of Hepatology 2012;56:225-33. [DOI: 10.1016/j.jhep.2011.04.022] [Cited by in Crossref: 143] [Cited by in F6Publishing: 124] [Article Influence: 14.3] [Reference Citation Analysis]
18 Dondeti MF, El-Maadawy EA, Talaat RM. Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol 2016; 22(30): 6800-6816 [PMID: 27570418 DOI: 10.3748/wjg.v22.i30.6800] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
19 Motawi T, Shaker OG, Hussein RM, Houssen M. Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection. Balkan J Med Genet 2016;19:35-44. [PMID: 28289587 DOI: 10.1515/bjmg-2016-0034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Matsuura K, Tanaka Y. Host genetic variants influencing the clinical course of hepatitis C virus infection. J Med Virol. 2016;88:185-195. [PMID: 26211651 DOI: 10.1002/jmv.24334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
21 Vieira DA, da Cunha LR, da Silva CB, Almeida MTB, Gomes AD, de Faria CLL Jr, Teixeira R, Neves FS, Rocha GA, de Melo FF, de Magalhães Queiroz DM, Silva LD. The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C. Qual Life Res 2019;28:1531-42. [PMID: 30734130 DOI: 10.1007/s11136-019-02129-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Bogdanović Z, Marinović-Terzić I, Kuret S, Jerončić A, Bradarić N, Forempoher G, Polašek O, Anđelinović Š, Terzić J. The impact of IL-6 and IL-28B gene polymorphisms on treatment outcome of chronic hepatitis C infection among intravenous drug users in Croatia. PeerJ 2016;4:e2576. [PMID: 27812403 DOI: 10.7717/peerj.2576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Kanda T, Jiang X, Nakamoto S, Nakamura M, Miyamura T, Wu S, Yokosuka O. Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. Cytokine. 2013;64:577-583. [PMID: 24041672 DOI: 10.1016/j.cyto.2013.08.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rehman SU, Rauf M, Abbas Z, Hamed MH, Qadri I. Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection. Viral Immunol 2016;29:536-45. [PMID: 27676210 DOI: 10.1089/vim.2016.0062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T. New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep 2014;2:171-83. [PMID: 26594598 DOI: 10.1007/s40139-014-0053-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Coppola N, Pisaturo M, Sagnelli C, Onorato L, Sagnelli E. Role of genetic polymorphisms in hepatitis C virus chronic infection. World J Clin Cases 2015; 3(9): 807-822 [PMID: 26380828 DOI: 10.12998/wjcc.v3.i9.807] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
27 Tosa M, Watanabe A, Ghazizadeh M. IL-6 Polymorphism and Susceptibility to Keloid Formation in a Japanese Population. Journal of Investigative Dermatology 2016;136:1069-72. [DOI: 10.1016/j.jid.2016.01.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Matsuura K, Tanaka Y. Host genetic variations associated with disease progression in chronic hepatitis C virus infection. Hepatol Res 2018;48:127-33. [PMID: 29235266 DOI: 10.1111/hepr.13042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
29 Song Y, Yang X, Shen Y, Wang Y, Xia X, Zhang AM. STAT3 signaling pathway plays importantly genetic and functional roles in HCV infection. Mol Genet Genomic Med 2019;7:e821. [PMID: 31219249 DOI: 10.1002/mgg3.821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]